Tell me about follicular lymphoma
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
I'll provide you with a comprehensive overview of follicular lymphoma (FL) based on the NCCN Guidelines.
According to the 2024 NCCN Guidelines for Patients with Follicular Lymphoma:
Key Characteristics:
- FL is a slow-growing (indolent) type of non-Hodgkin lymphoma (NHL)
- It develops from B lymphocytes, which are a type of white blood cell
- The disease is characterized by abnormal B lymphocytes forming clusters (follicles) in lymph nodes and sometimes other tissues
How It Develops:
- FL starts in the temporary germinal centers (GCs) of lymph nodes
- These germinal centers normally form in response to infection or inflammation
- In FL, the cells within these centers grow without proper regulation
Types and Grades: The NCCN Guidelines identify several types:
- Classic FL (cFL) - Grades 1 or 2
- Uncommon FL (uFL)
- Pediatric-type FL (PTFL)
- Transformed FL (can transform into more aggressive DLBCL)
Important Points to Know:
- Not everyone with FL needs immediate treatment
- While FL typically forms tumors in lymph nodes, it can appear in other parts of the body
- Almost all FL cases have a specific chromosome translocation (t(14:18)) or elevated levels of BCL2 protein
The Leukemia & Lymphoma Society and NCCN both emphasize that FL is typically manageable, though not usually curable. It's important to work with your healthcare team to determine the best treatment approach for your specific situation.
Always consult with your healthcare providers for personalized medical advice, as they can take into account your specific circumstances and medical history.
Sources:
- NCCN Guidelines for Patients: Follicular Lymphoma, 2024 Edition, Pages 5-9
- NCCN Guidelines for Patients: Follicular Lymphoma, 2024 Edition, Pages 9-11
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Lymphoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: